PuSH - Publication Server of Helmholtz Zentrum München

Hanke, S.* ; Tindall, C.* ; Pippel, J.* ; Ulbricht, D.* ; Pirotte, B.* ; Reboud-Ravaux, M.* ; Heiker, J.T. ; Sträter, N.*

Structural studies on the inhibitory binding mode of aromatic coumarinic esters to human kallikrein-related peptidase 7.

J. Med. Chem. 63, 5723-5733 (2020)
Publ. Version/Full Text Postprint DOI
Open Access Green
The serine protease kallikrein-related peptidase 7 (KLK7) is a member of the human tissue kallikreins. Its dysregulation leads to pathophysiological inflammatory processes in the skin. Furthermore, it plays a role in several types of cancer. For the treatment of KLK7-associated diseases, coumarinic esters have been developed as small-molecule enzyme inhibitors. To characterize the inhibition mode of these inhibitors, we analyzed structures of the inhibited protease by X-ray crystallography. Electron density shows the inhibitors covalently attached to His57 of the catalytic triad. This confirms the irreversible character of the inhibition process. Upon inhibitor binding, His57 undergoes an outward rotation; thus, the catalytic triad of the protease is disrupted. Besides, the halophenyl moiety of the inhibitor was absent in the final enzyme-inhibitor complex due to the hydrolysis of the ester linkage. With these results, we analyze the structural basis of KLK7 inhibition by the covalent attachment of aromatic coumarinic esters.
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Keywords Corneum Chymotryptic Enzyme; Human Tissue Kallikreins; Alpha-chymotrypsin; Lamellar Granules; Serine Proteases; Specificity; Klk7; Derivatives; Epidermis; Acid
ISSN (print) / ISBN 0022-2623
e-ISSN 1520-4804
Quellenangaben Volume: 63, Issue: 11, Pages: 5723-5733 Article Number: , Supplement: ,
Publisher American Chemical Society (ACS)
Publishing Place 1155 16th St, Nw, Washington, Dc 20036 Usa
Reviewing status Peer reviewed
Institute(s) Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)